No-carrier-added (18F)-N-methylspiroperidol

Shiue, Chyng-Yann; Fowler, Joanna S; Wolf, Alfred P

Title: No-carrier-added (18F)-N-methylspiroperidol

Abstract

There is disclosed a radioligand labeled with a positron emitting radionuclide suitable for dynamic study in living humans with positron emission transaxial tomography. [.sup.18 F]-N-methylspiroperidol, exhibiting extremely high affinity for the dopamine receptors, provides enhanced uptake and retention in the brain concomitant with reduced radiation burden. These characteristics all combine to provide [.sup.18 F]-N-methylspiroperidol as a radioligand superior to known radioligands for mapping dopamine receptors in normal and disease states in the living brain. Additionally, a new synthetic procedure for this material is disclosed.

Inventors:

Shiue, Chyng-Yann ^[1]; Fowler, Joanna S ^[2]; Wolf, Alfred P ^[3]

East Setauket, NY
Bellport, NY
Setauket, NY

Issue Date:: 1993-01-01

Research Org.:: Associated Universities, Inc., Upton, NY (United States)

OSTI Identifier:: 875158

Patent Number(s):: H1209

Assignee:: United States of America as represented by United States (Washington, DC)

DOE Contract Number:: AC02-76CH00016

Resource Type:: Patent

Country of Publication:: United States

Language:: English

Subject:: no-carrier-added; 18f; -n-methylspiroperidol; disclosed; radioligand; labeled; positron; emitting; radionuclide; suitable; dynamic; study; living; humans; emission; transaxial; tomography; 18; exhibiting; extremely; affinity; dopamine; receptors; provides; enhanced; uptake; retention; brain; concomitant; reduced; radiation; burden; characteristics; combine; provide; superior; radioligands; mapping; normal; disease; additionally; synthetic; procedure; material; positron emission; provides enhanced; dopamine receptor; transaxial tomography; emission transaxial; emitting radionuclide; dynamic study; living human; living humans; /424/999/

Citation Formats


                    Shiue, Chyng-Yann, Fowler, Joanna S, and Wolf, Alfred P. No-carrier-added (18F)-N-methylspiroperidol.  United States: N. p., 1993. 
        Web.

Copy to clipboard


                    Shiue, Chyng-Yann, Fowler, Joanna S, & Wolf, Alfred P. No-carrier-added (18F)-N-methylspiroperidol.  United States.

Copy to clipboard


                    Shiue, Chyng-Yann, Fowler, Joanna S, and Wolf, Alfred P. Fri .  
        "No-carrier-added (18F)-N-methylspiroperidol".  United States.  https://www.osti.gov/servlets/purl/875158.

Copy to clipboard


                    
@article{osti_875158,

  title        = {No-carrier-added (18F)-N-methylspiroperidol},

  author       = {Shiue, Chyng-Yann and Fowler, Joanna S and Wolf, Alfred P},

  abstractNote = {There is disclosed a radioligand labeled with a positron emitting radionuclide suitable for dynamic study in living humans with positron emission transaxial tomography. [.sup.18 F]-N-methylspiroperidol, exhibiting extremely high affinity for the dopamine receptors, provides enhanced uptake and retention in the brain concomitant with reduced radiation burden. These characteristics all combine to provide [.sup.18 F]-N-methylspiroperidol as a radioligand superior to known radioligands for mapping dopamine receptors in normal and disease states in the living brain. Additionally, a new synthetic procedure for this material is disclosed.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {1993},

  month        = {1}

}

Copy to clipboard

Patent:

View Patent

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Imaging dopamine receptors in the human brain by positron tomography
journal, September 1983

Wagner, H.; Burns, H.; Dannals, R.
Science, Vol. 221, Issue 4617
https://doi.org/10.1126/science.6604315

Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors
journal, June 1980

Tewson, T. J.; Raichle, M. E.; Welch, M. J.
Brain Research, Vol. 192, Issue 1
https://doi.org/10.1016/0006-8993(80)91032-X

Similar Records in DOE Patents and OSTI.GOV collections:

No-carrier-added [.sup.18 F]-N-fluoroalkylspiroperidols

Patent Shiue, Chyng-Yann [East Setauket, NY]; Wolf, Alfred P [Setauket, NY]; Bai, Lan-Qin [Upton, NY]; ...

There is disclosed radioligands labeled with the position emitting radionuclide [.sup.18 F] suitable for dynamic study in living humans with position emission transaxial tomography. These new [.sup.18 F]-N-fluoroalkylspiroperidols, wherein the alkyl group contains from 2-6 carbon atoms, exhibit extremely high affinity for the dopamine receptors and provide enhanced uptake and retention in the brain concomitant with reduced radiation burden. These characteristics all combine to make these new radioligands useful for mapping dopamine receptors in normal and disease states in the living brain. Additionally, a new synthetic procedure for these radioligands as well as a new procedure for preparing the radiolabeledmore »« less
Full Text Available
No-carrier-added (/sup 18/F)-N-methylspiroperidol

Patent Shiue, C Y; Fowler, J S; Wolf, A P

The present invention is directed to the synthesis of a radioligand, labeled with a positron emitting radionuclide which is suitable for dynamic studies in humans using positron emission transaxial tomography. No-carrier-added (NCA) (/sup 18/F)-N-methylspiroperiodl is prepared from four different sustrates: p-nitrobenzonitrile, cyclopropyl p-nitrophenyl ketone, p-cyclopropanoyl-N,N,N-trimethylanilinium iodide and p-cyclopropanoyl-N,N,N-trimethylanilinium perchlorate. The process for the production of NCA (/sup 18/F)-N-methylspiroperidol is a nucleophilic aromatic substitution reaction. Furthermore, the compound of this invention is shown to be effective as a new drug of choice for in vivo examination of dopamine binding sites in a human brain. In particular, this drug is primarily usefulmore »« less
Process and targets for production of no-carrier-added radiotin

Patent Srivastava, Suresh C; Zhuikov, Boris Leonidovich; Ermolaev, Stanislav Victorovich; ...

One embodiment of the present invention includes a process for production and recovery of no-carrier-added radioactive tin (NCA radiotin). An antimony target can be irradiated with a beam of accelerated particles forming NCA radiotin, followed by separation of the NCA radiotin from the irradiated target. The target is metallic Sb in a hermetically sealed shell. The shell can be graphite, molybdenum, or stainless steel. The irradiated target can be removed from the shell by chemical or mechanical means, and dissolved in an acidic solution. Sb can be removed from the dissolved irradiated target by extraction. NCA radiotin can be separatedmore »« less
Full Text Available
Methods for chemical recovery of non-carrier-added radioactive tin from irradiated intermetallic Ti-Sb targets

Patent Lapshina, Elena V [Troitsk, RU]; Zhuikov, Boris L [Troitsk, RU]; Srivastava, Suresh C [Setauket, NY]; ...

The invention provides a method of chemical recovery of no-carrier-added radioactive tin (NCA radiotin) from intermetallide TiSb irradiated with accelerated charged particles. An irradiated sample of TiSb can be dissolved in acidic solutions. Antimony can be removed from the solution by extraction with dibutyl ether. Titanium in the form of peroxide can be separated from tin using chromatography on strong anion-exchange resin. In another embodiment NCA radiotin can be separated from iodide solution containing titanium by extraction with benzene, toluene or chloroform. NCA radiotin can be finally purified from the remaining antimony and other impurities using chromatography on silica gel.more »« less
Full Text Available
No-carrier-added [1.sup.11 c]putrescine

Patent McPherson, Daniel W [Baltimore, MD]; Fowler, Joanna S [Bellport, NY]; Wolf, Alfred P [Setauket, NY]

The invention relates to a new radiolabeled imaging agent, no-carrier-added [1-.sup.11 C]putrescine, and to the use of this very pure material as a radiotracer with positron emission tomography for imaging brain tumors. The invention further relates to the synthesis of no-carrier-added [1-.sup.11 C]putrescine based on the Michael addition of potassium .sup.11 C-labeled cyanide to acrylonitrile followed by reduction of the .sup.11 C-labeled dinitrile. The new method is rapid and efficient and provides radiotracer with a specific activity greater than 1.4 curies per millimol and in a purity greater than 95%.
Full Text Available

Similar Records

Title: No-carrier-added (18F)-N-methylspiroperidol

Abstract

Citation Formats

Imaging dopamine receptors in the human brain by positron tomography journal, September 1983

Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors journal, June 1980

Imaging dopamine receptors in the human brain by positron tomography
journal, September 1983

Preliminary studies with [18F]haloperidol: a radioligand for in vivo studies of the dopamine receptors
journal, June 1980